Fortuna Pharma Laboratories Private Limited - Company Profile

It is a chemicals private limited company based in Bangalore, Karnataka, India, established in 2011.
2011 Bangalore, Karnataka, India Struck Off
Last Updated:
Access Report
About Fortuna Pharma Laboratories Private Limited

Fortuna Pharma Laboratories Private Limited, a struck off private limited company, was established on 09 February 2011 in Bangalore, Karnataka, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232KA2011PTC056982. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mushtaq Ali (Director), Karunakaramenon Pathayathodiyil Murali Mohan (Director), Vittaladas Vedavyasa Bhat (Director). It is based at No.344, 9Th Main, Dollars Layout J P Nagar Iv Phase, Bangalore, Karnataka, 560078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232KA2011PTC056982

  • Registration Number

    056982

  • Incorporation Date

    09 February 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 5 Days
Company report

Fortuna Pharma Laboratories Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fortuna Pharma Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Fortuna Pharma Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Mushtaq Ali Director 09 Feb 2011 Current
Karunakaramenon Pathayathodiyil Murali Mohan Director 09 Feb 2011 Current
Vittaladas Vedavyasa Bhat Director 09 Feb 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fortuna Pharma Laboratories.

Enhance accessibility to Fortuna Pharma Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Fortuna Pharma Laboratories revenue growth over time
Fortuna Pharma Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fortuna Pharma Laboratories?

Unlock access to Fortuna Pharma Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fortuna Pharma Laboratories?

Unlock and access historical data on people associated with Fortuna Pharma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fortuna Pharma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortuna Pharma Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fortuna Pharma Laboratories
Recent Activity within the Organization
  • Director Appointment

    Mushtaq Ali was appointed as a Director was appointed as a Director on 09 Feb 2011 & has been associated with this company since 15 years 5 days . was recorded as a recent event.

  • Director Appointment

    The activity Karunakaramenon Pathayathodiyil Murali Mohan was appointed as a Director was appointed as a Director on 09 Feb 2011 & has been associated with this company since 15 years 5 days . was completed.

  • Director Appointment

    The activity Vittaladas Vedavyasa Bhat was appointed as a Director was appointed as a Director on 09 Feb 2011 & has been associated with this company since 15 years 5 days . was completed.

  • Company Incorporation

    Fortuna Pharma Laboratories Private Limited was registered on 09 Feb 2011 with Roc Bangalore & aged 15 years 5 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fortuna Pharma Laboratories Private Limited?

The CIN of Fortuna Pharma Laboratories Private Limited is U24232KA2011PTC056982.

Where is Fortuna Pharma Laboratories Private Limited headquartered?

Fortuna Pharma Laboratories Private Limited is headquartered at No.344, 9Th Main, Dollars Layout J P Nagar Iv Phase, Bangalore, Karnataka, 560078.

When was Fortuna Pharma Laboratories Private Limited incorporated?

Fortuna Pharma Laboratories Private Limited was incorporated on 09 February 2011.

Who are the current directors of Fortuna Pharma Laboratories Private Limited?

The current directors of Fortuna Pharma Laboratories Private Limited are

What is the primary industry of Fortuna Pharma Laboratories Private Limited?

The primary industry of Fortuna Pharma Laboratories Private Limited is Chemicals.

Is Fortuna Pharma Laboratories Private Limited a listed company?

Fortuna Pharma Laboratories Private Limited is unlisted.

What is the capital structure of Fortuna Pharma Laboratories Private Limited?

The authorized capital of Fortuna Pharma Laboratories Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available